Menu Search
Equities

Catheter Precision Inc

4RM:MUN

Catheter Precision Inc

Actions
  • Price (EUR)0.55
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-48.36%
  • Beta--
Data delayed at least 15 minutes, as of May 20 2024 07:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

  • Revenue in USD (TTM)439.00k
  • Net income in USD-6.85m
  • Incorporated2018
  • Employees14.00
  • Location
    Catheter Precision Inc1670 HIGHWAY 160 WEST, SUITE 205FORT MILL 29708United StatesUSA
  • Phone+1 (973) 691-2000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.ramed.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.